MedTrace Logo

Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections

NCT06711575 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-12-02

No results posted yet for this study

Summary

The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.

Conditions

  • Infectious Diseases of Spine

Interventions

DRUG

Anti-Infective Drugs

Anti-infective drugs are administered using the traditional clinical dosing regimen, with no interventions.

Sponsors & Collaborators

  • Shandong Public Health Clinical Center

    collaborator OTHER_GOV

  • Shandong University

    lead OTHER

Principal Investigators

  • Wei Zhao, Ph.D · Shandong University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-12
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06711575 on ClinicalTrials.gov